Investment
Features
FeesSafety
Academy
More
Pluang+

Class action lawsuit filed against Qfin Holdings over alleged misleading statements on business stability.

Market News
29 Sep 2026
PRNewsWire
View Source
Bearish
Class action lawsuit filed against Qfin Holdings over alleged misleading statements on business stability.

Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Qfin Holdings securities between March 18 and August 25, 2026. The lawsuit alleges that Qfin made false or misleading statements about the resilience and stability of its business amid regulatory challenges, downplaying the negative impact on its financial results. Investors who bought Qfin securities during this period may be eligible for compensation. Those interested in joining the lawsuit or serving as lead plaintiff must act by November 27, 2026.

Qfin Holdings, Inc. securities fraud lawsuit opportunity is presented here with Pluang's Financials-sector market data as of Sep 30, 2026 01:11 WIB. Of 85 priced Financials-sector US stocks tradable on Pluang, 22 rose and 60 fell today. Notable movers include FLG (Flagstar Bank NA) at USD 11.83 with a -1.74% change, CLSK (CleanSpark Inc) at USD 13.57 with a +1.72% change and a Pluang order activity of 11% Sell / 89% Buy, and WAL (Western Alliance Bancorporation) at USD 75.25 with a -1.70% change.

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
20 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
First Financial Bank to open new full-service branch in Bee Cave, Texas, expanding in Austin area.

First Financial Bank to open new full-service branch in Bee Cave, Texas, expanding in Austin area.

First Financial Bank, a subsidiary of First Financial Bankshares, Inc., announced it will open a new full-service branch in Bee Cave, Texas, in late October. This marks the bank's 81st location and strengthens its presence in Central Texas and the gr...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App